Cite
HARVARD Citation
Jin, Y. et al. (2023). The regulatory approvals of immune checkpoint inhibitors in China and the United States: A cross‐national comparison study. International journal of cancer. 152 (11), pp. 2351-2361. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jin, Y. et al. (2023). The regulatory approvals of immune checkpoint inhibitors in China and the United States: A cross‐national comparison study. International journal of cancer. 152 (11), pp. 2351-2361. [Online].